ProPhase Labs, Inc. — Director's Dealing 2023

Jan 13, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2023-01-13

Reporting Person: Morse Robert A. Jr. (Controller)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$12.01	2029-10-09	Common Stock, par value $0.0005 (50000)		Direct

Footnotes

F1: The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.